Wealth Enhancement Advisory Services
MED icon

Wealth Enhancement Advisory Services’s Medifast MED Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
10,683
+385
+4% +$4.44K ﹤0.01% 3768
2026
Q1 		$107K Buy
+10,298
New +$111K ﹤0.01% 3304

Other funds holding MED

SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $151M AUM 22.54% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's MED Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Medifast (MED) stake by 3.7% in Q2 2026, buying an estimated $4.44K and bringing the position to 10,683 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #3768.

Wealth Enhancement Advisory Services first reported a position in MED in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Wealth Enhancement Advisory Services held 10,683 shares of Medifast worth $115K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 385 Medifast shares in Q2 2026, an estimated $4.44K.
  • Medifast made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3768 holding.
  • Wealth Enhancement Advisory Services first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.